Roivant Sciences (ROIV) Amortization of Deferred Charges (2021 - 2026)

Roivant Sciences (ROIV) has 5 years of Amortization of Deferred Charges data on file, last reported at $6.4 million in Q4 2025.

• Quarterly Amortization of Deferred Charges rose 31.64% year-over-year to $6.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.2 million (up 15.98% YoY) and the FY2026 annual result came in at $8.3 million, up 20.94% from the prior year.
• Amortization of Deferred Charges climbed to $6.4 million in Q4 2025, from $1.9 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $6.4 million in Q4 2025 to a low of $1.6 million in Q3 2024.
• A 5-year average of $3.3 million and a median of $2.0 million in 2022 frame the typical range for Amortization of Deferred Charges.
• Annual changes were most pronounced in 2023 — Amortization of Deferred Charges dropped 22.56% — and 2025, when it soared 31.64%.
• Tracing ROIV's Amortization of Deferred Charges over 5 years: stood at $5.4 million in 2021, then grew by 11.2% to $6.0 million in 2022, then retreated by 16.01% to $5.0 million in 2023, then declined by 3.49% to $4.9 million in 2024, then soared by 31.64% to $6.4 million in 2025.
• The last three Amortization of Deferred Charges figures came in at $6.4 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.